ripekg:retraction-notice/59331Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1155%2F2022%2F7864114 |
ripekg:retraction-notice/59331Efficacy and Risk Factors of Pyrrotinib in Second- and Third-Line Treatments for HER2-Positive Advanced Breast Cancer |
ripe:concerns |
ripekg:work/10.1155%2F2022%2F7864114 |
ripekg:work/10.1155%2F2022%2F7864114 |
prism:doi |
10.1155/2022/7864114 |
ripekg:work/10.1155%2F2022%2F7864114 |
prism:publicationDate |
2022-09-17 |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
node1 |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
rdfs:Resource |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
owl:Thing |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
prov:Entity |
ripekg:work/10.1155%2F2022%2F7864114 |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1155%2F2022%2F7864114 |
owl:sameAs |
https://semopenalex.org/work/W4297259400 |